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MRICerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) often
presents with a history of migraine with aura and eventualmanifestations of dementia with unrelenting, repeat-
ed cerebral vascular insults. Only 6–10% of patients with CADASIL have been reported to develop seizures, and
status epilepticus (SE) is exceedingly rare. Here, we describe a patient who presented with recurrent SE, with
eventual biopsy diagnosis of CADASIL.
An 80-year-old woman presented to our hospital three times in two years with decreased level of consciousness
and subtle intermittent right-sided upper extremity and facial twitching. There was no known signiﬁcant family
history and no pastmedical history for seizures, stroke, migraine headache, or overt dementia. Electroencephalog-
raphy revealed recurrent focal seizures with left hemispheric onset and evolution, fulﬁlling the criteria for focal SE
each time. All three admissions required sedation with midazolam to control seizure activity, in addition to high
doses of multiple antiepileptic drugs. Brain MRI repeatedly showed extensive abnormalities in the periventricular
and deepwhitematter, subcortical whitematter, and bilateral basal ganglia. Skin biopsywas obtained on the third
admission, and electron microscopy showed numerous deposits of granular osmiophilic material, which are
pathognomonic for CADASIL. Detailed investigations failed to reveal any other etiology for the patient's condition.
This case illustrates the potential for nonconvulsive SE to be the sole manifestation of CADASIL. With the appro-
priate brain MRI ﬁndings, CADASIL should be added to the list of rare causes of SE.
© 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Cerebral autosomal dominant arteriopathy with subcortical infarcts
and leukoencephalopathy (CADASIL) is a disease of the vascular smooth
muscle typically caused by a mutation of the Notch3 gene [1]. Cerebral
autosomal dominant arteriopathy with subcortical infarcts and
leukoencephalopathy often presents with a history of migraine with
aura and eventualmanifestations of dementia with unrelenting, repeat-
ed cerebral vascular insults [1,2]. Diagnoses have been made singularly
or by a combination of genetic testing and skin biopsy [1]. Only 6–10%arteriopathywithsubcortical in-
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. This is an open access article underof patients with CADASIL have been reported to develop seizures, and
status epilepticus (SE) is exceedingly rare [1–3]. Here, we describe a pa-
tient who presented three times in two years with SE of an unknown
cause, with eventual biopsy diagnosis of CADASIL.2. Case report
An 80-year-old woman presented to our hospital three times in two
years with a decreased level of consciousness and subtle intermittent
right-sided upper extremity and facial twitching. Her past medical his-
tory was only signiﬁcant for well-controlled hypertension, with no
history of seizures, migraine headaches, strokes, or overt dementia.
There was no known signiﬁcant family history.
Electroencephalography revealed recurrent focal seizures with left
hemispheric onset and evolution, fulﬁlling the criteria for focal SE each
time (Fig. 1). Brain MRI repeatedly showed extensive abnormalities in
the periventricular and deep white matter, subcortical white matter,
and bilateral basal ganglia (Fig. 2). No acute infarcts were seen. Cerebro-
spinalﬂuid studies consistently revealed culture-negative, predominantly
neutrophilic pleocytosis (range: 27 to 92). Otherwise, detailed andthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1. A and B. EEG ﬁndings: A: EEG revealed recurrent focal seizures with left hemispheric onset and evolution, fulﬁlling the criteria for focal status epilepticus. B: Interictal left posterior
quadrant sharp waves.
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fectious, inﬂammatory, paraneoplastic, etc.) for the patient's condition.
All three admissions required sedation with midazolam to control
seizure activity in addition to high doses of multiple antiepileptic
drugs. The patient made a slow but full recovery after the ﬁrst and
second episodes, following ﬁve-week and four-week hospital stays, re-
spectively. The third episode occurred despite the regular intake ofantiepileptic drugs (valproate and levetiracetam), and the patient
remained minimally responsive afterwards. The patient did eventually
require tracheostomy and PEG tube placement and was discharged to
a nursing home. Months after discharge, she is still in a nursing home
with unimproved mental status.
On the third admission, the extensiveMRI changes and recurrent ep-
isodes of stupor prompted consideration of CADASIL. Skin biopsy was
Fig. 2. Imaging: BrainMRI repeatedly showedextensive abnormalities in theperiventricular
and deep white matter, subcortical white matter, and bilateral basal ganglia.
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gaps and discontinuities in the perivascular smooth muscle layer with
numerous deposits of granular osmiophilic material (Fig. 3). These
ﬁndings are reported to be diagnostic of CADASIL [1]. Genetic testing
was not pursued.Fig. 3. Skin biopsyﬁndings: Electronmicroscopic images showed striking gaps and discon-
tinuities in the perivascular smoothmuscle layer, vacuolizationwithin the smoothmuscle,
and numerous deposits of granular osmiophilic material (red circles) —much of which,
because of the degree of vascular wall breakdown, was free-ﬂoating.3. Discussion
To our knowledge, this is the ﬁrst reported case of CADASIL present-
ing as nonconvulsive SE, without the other typical manifestations.
Seizures are seen in a small percentage of patients with CADASIL, but
they often follow a stroke and are not typically the ﬁrst manifestation
of the disease [1,2]. Status epilepticus is also very rare in this disease;
we found only one published case report of EEG-proven nonconvulsive
SE in a patientwith established diagnosis of CADASIL [3]. Schon et al. de-
scribed six patients with CADASIL with a reversible acute encephalopa-
thy; four of them had seizures during their hospitalization. However,
their EEG data did not show ictal seizure activity, although the record-
ings were apparently brief and not continuous [4]. Similar case reports
can be found, again lacking adequate EEG data [5,6]. It is possible that
the diagnosis of nonconvulsive SE was missed in at least some of these
cases, suggesting that this complication of CADASIL is underdiagnosed.
Our case is also peculiar for its late onset. Manifestations of CADASIL
usually start in early or mid-adulthood, with gradual accumulation of
deﬁcits. However, the phenotypic and prognostic variability has already
been emphasized with 14% of biopsy-proven patients over 60 years of
age having no disability at all [2]. Also, Mourad et al. reported on 4 pa-
tients diagnosed after age 60 [7]. The consistent CSF pleocytosis in this
case is unusual for CADASIL [8], but the co-occurrence of SE may be a
confounding factor.This case illustrates the potential for nonconvulsive SE to be the sole
manifestation of CADASIL. With the appropriate brain MRI ﬁndings,
CADASIL should be added to the list of rare causes of SE, regardless of
a subject's advanced age.
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